A detailed history of Assetmark, Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Assetmark, Inc holds 4,891 shares of COLL stock, worth $142,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,891
Previous 5,415 9.68%
Holding current value
$142,572
Previous $174,000 8.05%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$31.4 - $39.07 $16,453 - $20,472
-524 Reduced 9.68%
4,891 $188,000
Q2 2024

Aug 13, 2024

BUY
$31.36 - $39.99 $16,119 - $20,554
514 Added 10.49%
5,415 $174,000
Q1 2024

May 06, 2024

SELL
$31.23 - $40.91 $16,989 - $22,255
-544 Reduced 9.99%
4,901 $190,000
Q4 2023

Feb 09, 2024

BUY
$21.16 - $30.8 $23,445 - $34,126
1,108 Added 25.55%
5,445 $167,000
Q3 2023

Oct 27, 2023

BUY
$21.23 - $24.28 $5,965 - $6,822
281 Added 6.93%
4,337 $96,000
Q2 2023

Aug 11, 2023

BUY
$21.06 - $24.0 $25,924 - $29,544
1,231 Added 43.58%
4,056 $87,000
Q1 2023

May 05, 2023

BUY
$23.0 - $29.88 $20,355 - $26,443
885 Added 45.62%
2,825 $67,000
Q4 2022

Feb 10, 2023

BUY
$16.14 - $23.55 $4,260 - $6,217
264 Added 15.75%
1,940 $45,000
Q3 2022

Nov 01, 2022

BUY
$15.46 - $20.1 $8,889 - $11,557
575 Added 52.23%
1,676 $27,000
Q2 2022

Aug 03, 2022

BUY
$14.22 - $20.88 $9,186 - $13,488
646 Added 141.98%
1,101 $20,000
Q1 2022

May 13, 2022

BUY
$17.2 - $22.5 $7,826 - $10,237
455 New
455 $9,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $995M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.